Ashish Kamat, Professor and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, shared on X:
“Thrilled to welcome over 100 global experts and patient advocates to Houston for IBCG25!
Together we’ll focus on two crucial goals: integrating bladder cancer biomarkers into clinical practice, and developing tools to better monitor and address local bladder toxicity – guided by the patient voice.
Both topics reflect our IBCG mission: to create real-world solutions that improve outcomes and provide practical tools for patients worldwide; through collaboration, collaboration and… more collaboration!”
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared Ashish M. Kamat’s post on X:
“Big two days ahead! All things Bladder Cancer new science, new insights, and turning data practice. Honored to represent Cleveland Clinic Urology with Shilpa Gupta.”
More posts featuring Ashish Kamat.